Clinical evaluation of a new measles-mumps-rubella trivalent vaccine

Am J Dis Child. 1975 Dec;129(12):1408-12. doi: 10.1001/archpedi.1975.02120490026008.

Abstract

In a series of clinical studies of a combined measles (Schwarz strain), mumps (Jeryl Lynn strain), and rubella (Cendehill strain) vaccine, 1,481 children received the vaccine or a placebo. The vaccine did not cause any significant reactions. The frequencies of mild, transient fever or rash or both in triple-susceptible vaccinees were similar to those that follow use of Schwarz strain measles vaccine alone. Measles, mumps, and rubella seroconversion rates in triple-susceptible vaccinees ranged from 95% to 100%. Geometric mean antibody titers were as high as those that usually result from use of these same virus strains as monovalent vaccines.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Antibodies, Viral / analysis
  • Antibody Formation
  • Child
  • Child, Preschool
  • Drug Eruptions / etiology
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Fever / etiology
  • Humans
  • Immunization
  • Infant
  • Male
  • Measles Vaccine / administration & dosage*
  • Measles Vaccine / adverse effects
  • Mumps Vaccine / administration & dosage*
  • Mumps Vaccine / adverse effects
  • Placebos
  • Rubella Vaccine / administration & dosage*
  • Rubella Vaccine / adverse effects

Substances

  • Antibodies, Viral
  • Measles Vaccine
  • Mumps Vaccine
  • Placebos
  • Rubella Vaccine